Previous close | 9.10 |
Open | 8.05 |
Bid | 7.80 |
Ask | 8.10 |
Strike | 40.00 |
Expiry date | 2024-10-18 |
Day's range | 8.05 - 8.05 |
Contract range | N/A |
Volume | |
Open interest | 109 |
If you are building a properly diversified stock portfolio, the chances are some of your picks will perform badly. But...
We recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss whether Exact Sciences Corporation (NASDAQ:EXAS) is the gene therapy stock with the greatest potential. Gene therapy involves treating illnesses by modifying, replacing, or supplementing faulty or missing genes responsible for a disease. This approach […]
Exact Sciences (EXAS) has numerous competitors, given the large market for colorectal cancer screening.